Lindazinc

Each tablet contains:

Active substance:

• Zinc Sulfate USP (as monohydrate) 54.89 mg eq. elemental zinc 20 mg

Excipients:

• corn starch, microcrystalline cellulose, calcium hydrogen phosphate, purified talc, magnesium stearate, sodium starch glycolate (type A), crospovidone XL-10, vanilla flavor (dry), aspartame, colloidal anhydrous silica, microcrystalline cellulose (PH 102).

• prevention and elimination of hypozincemia, which can occur with liver diseases (especially with cirrhosis), steatorrhea, with renal diseases, hypovitaminosis D, with burns, psoriasis, enteritis, helminthic infestation, hypogonadism, acrodermatitis enteropathica, alopecia areata, cerebral palsy;
• with increased excretion of zinc in diabetes mellitus, diffuse connective tissue diseases, collagenoses (rheumatoid arthritis, lupus erythematosus);
• with long-term use of glucocorticoids;
• low testosterone levels, when this is caused by age-related changes, as well as other pathologies;
• to maintain immunity;
• during pregnancy and lactation;
• colds.

For therapeutic purposes, it is prescribed to eliminate hypozincemia that has already occurred (enteropathic acrodermatitis).

For preventive purposes, based on the daily requirement for zinc:

• infants – 10-15 mg per day;
• older children – 15-20 mg per day;
• adults – 15-25 mg per day (1 tablet of 20 mg 1 time per day on an empty stomach, with plenty of water – a glass of water).

For therapeutic purposes – 20 mg 2-3 times a day.

Enteropathic acrodermatitis, alopecia areata:

• adults and children over 4 years old – 40 mg (2 tablets of 20 mg) – 3 times a day 1 hour before or 2 hours after meals.
  Once clinical improvement is achieved, the dose is reduced to 40 mg 2 times a day, and then 40 mg per day until the symptoms of the disease completely disappear.

Malignant alopecia:

• adults – 40-80 mg 3 times a day; children over 4 years old – 40 mg 3 times a day.

Purulent and phlegmonous acne:

• adults – 40-80 mg per day; children over 4 years old – 40 mg per day.

The duration of treatment is determined by the doctor individually, depending on the degree of clinically proven zinc deficiency and the achieved therapeutic effect.